SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-23-013848
Filing Date
2023-11-07
Accepted
2023-11-07 10:30:48
Documents
7
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 13114
2 NEWS RELEASE fsd_ex991.htm EX-99.1 14387
3 NEWS RELEASE fsd_ex992.htm EX-99.2 14441
4 NEWS RELEASE fsd_ex993.htm EX-99.3 16320
5 fsd_ex991img2.jpg GRAPHIC 5969
6 fsd_ex993img2.jpg GRAPHIC 5964
7 fsd_ex992img2.jpg GRAPHIC 5968
  Complete submission text file 0001654954-23-013848.txt   84340
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 231382243
SIC: 2834 Pharmaceutical Preparations